APA

Sundy J. S., Becker M. A., Baraf H. S. B., Barkhuizen A., Moreland L. W., Huang W., Waltrip R. W., Maroli A. N. & Horowitz Z. (20100331). Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. : Arthritis and rheumatism.

Chicago

Sundy John S, Becker Michael A, Baraf Herbert S B, Barkhuizen Andre, Moreland Larry W, Huang William, Waltrip Royce W, Maroli Allan N and Horowitz Zeb. 20100331. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. : Arthritis and rheumatism.

Harvard

Sundy J. S., Becker M. A., Baraf H. S. B., Barkhuizen A., Moreland L. W., Huang W., Waltrip R. W., Maroli A. N. and Horowitz Z. (20100331). Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. : Arthritis and rheumatism.

MLA

Sundy John S, Becker Michael A, Baraf Herbert S B, Barkhuizen Andre, Moreland Larry W, Huang William, Waltrip Royce W, Maroli Allan N and Horowitz Zeb. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. : Arthritis and rheumatism. 20100331.